Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomics-guided treatment of hypertension with hydrochlorothiazide or perindopril
2015-001888-39Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrochlorothiazide and perindopril in essential hypertension (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Primary: Blood pressure reduction by genetic profile and drug. Started Sep 2016; status: completed.
02
Drugs
hydrochlorothiazideperindopril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2015-001888-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001888-39.